ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
ANALYSIS: We have the data to show calls for a single RBNZ mandate are misguided.
ANALYSIS: Fisher Funds milks the market rebound post-Covid, contrary to guidelines under the KiwiSaver Act.
ANALYSIS: The lender’s glib statements on loan repayments mask a more awkward reality.
ANALYSIS: Our apparent obsession with property investment is the scapegoat for other culprits.
ANALYSIS: Flaws in our energy market are apparent in fallout from last year’s blackout.
ANALYSIS: A private fund management spat has raised some questions about property development loans.
ANALYSIS: Fletcher Building is taking the heat for stockouts but it's a creature of a special environment.
ANALYSIS: The shutdown has left us exposed to sky-high fuel prices.
ANALYSIS: A $300m share buyback has left loyal shareholders worse off.
